Implementing the Eczema Society’s Practical Management Guide into Your Practice - Canadian Council On Continuing Education In Pharmacy (CCCEP)
Atopic dermatitis (AD) is a chronic, relapsing, and remitting inflammatory skin disease characterized by erythema, edema, xerosis, erosions/excoriations, oozing and crusting, and lichenification, with pruritus as the hallmark of the condition. This condition is very common and affects between 10% and 20% of children in developing countries.
Although once thought of as only a pediatric condition, data now shows that up to 10.2% patients have symptoms that persist into adulthood. A 3.2% prevalence of eczema, asthma, and hay fever was identified, suggesting AD is not uncommon in adult patients. Patient-reported rates of adult AD between 2.1% and 4.9%, most commonly of mild-to-moderate severity. A systematic review and meta-analysis suggests that there is no significant difference in AD prevalence before and after childhood.
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP).
Kirk Barber (MD, FRCPC)
Moe Abdallah (BSc., BSc. Pharm., R.Ph.)
Tom Smiley (BScPhm, PharmD, CTE)
Upon successful completion of this continuing education lesson, you will be better able to:
- Explore the pathophysiology, risk factors and patient impact of AD
- Review the common clinical presentation and diagnosis of AD
- Examine the role of non-pharmacological interventions in the management of AD
- Customize the pharmacological treatment for a specific AD patient
- Develop an eczema care plan for a patient with AD